Elitza Theel, Ph.D., explains how Mayo Clinic Laboratories' unique Histoplasma and Blastomyces test provides cost-effective evaluation for fungal infections that cause pulmonary illness. The assay reliably detects both Histoplasma and Blastomyces pathogens in a single test.(00:32) Will you please give us a brief introduction of yourself and your role at Mayo Clinic? (01:34) Can you tell us which specific group of patients this test would be best suited for, how a provider would determine a patient might benefit from this test, and when during the care process it should be ordered? (04:56) Can you explain how this new test is different, and why a provider might consider requesting it instead of the usual test? (08:00) When should the different tests be used? (09:34) Is this the only existing assay that can reliably detect antigen from both of these fungal pathogens?

Ver todos los episodios